In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The entire North India including Delhi-NCR is facing the brunt of severe cold these days. Cold wa
Corona has started spreading again in the country. It could also be the sound of the fourth wave.
After the humiliating nine-wicket defeat against Australia in the Indore Test, Indian captain Roh
Voting for the seventh phase of Lok Sabha elections is to be held on June 1. On th
Taliban crisis: Tajikistan did not give shelter to Ghani, now preparing to plead with America
President Ashraf Ghani, who fled Afghanistan, suffered a major setback when Tajikistan did not al
Gujarat Vidhan Sabha Election Date 2022: The Election Commission can announce the dates for the G
BSEB 12th Result 2022: The evaluation work of the results of Bihar Board Class 12th i.e. Intermed
Many countries of the world including India have seen a rapid increase in cases of infection due
Floods and landslides have wreaked havoc in the city of Petropolis in the Brazilian state of Rio
Terrorists have carried out another targeted killing in Kashmir. A bank manager living in Rajasth
